VRCANasdaq United States
Market cap
$87.268 M
$5.08 -5.22%
Close of 7 Aug 2026
Revenue
$35.6M
#2845 by revenue
Earnings
-$17.9M
Loss-making
Shares outstanding
17,178,786
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Verrica Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.